Patterns in the Data

With machine learning, a genomics company is moving into drug development, Technology Review reports.

Deep Genomics, which had been focusing on using its machine-learning tools to search for genetic changes that might be causal for certain diseases, is now setting its sights on developing drugs. According to Tech Review, Deep Genomics will first try its hand at developing drugs for Mendelian disorders.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers in the UK and Australia uncover genetic links between BMI and depression, the Guardian reports.

The Verge details the account of an academic who alleges her university retaliated against her after she complained of sexual harassment by her supervisor.

The New York Times writes that natural history museums are helping round out genetic studies with older specimens.

In PNAS this week: artemisinin resistance mutations in malaria parasites, ant-plant interactions over time, and more.